期刊
JOURNAL OF IMMUNOLOGY
卷 165, 期 8, 页码 4428-4436出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.165.8.4428
关键词
-
类别
资金
- NCI NIH HHS [R01 CA40163, P01 CA32737] Funding Source: Medline
- NIGMS NIH HHS [5T32 GM08375] Funding Source: Medline
The Notch transmembrane receptors play important roles in precursor survival and cell fate specification during hematopoiesis, To investigate the function of Notch and the signaling events activated by Notch in myeloid development, me expressed truncated forms of Notch1 or Notch2 proteins that either can or cannot activate the core binding factor 1 (CBF1) in 32D (clone 3) myeloblasts. 32D cells proliferate as blasts in the presence of the cytokines, GM-CSF or IL-3, but they initiate differentiation and undergo granulopoiesis in the presence of granulocyte CSF (G-CSP). 32D cells expressing constitutively active forms of Notch1 or Notch2 proteins that signal through the CBF1 pathway maintained significantly higher numbers of viable cells and exhibited less cell death during G-CSF induction compared with controls, They also displayed enhanced entry into granulopoiesis, and inhibited postmitotic terminal differentiation. In contrast, Notch1 constructs that either lacked sequences necessary for Coil binding or that failed to localize to the nucleus had little effect. Elevated numbers of viable cells during G-CSF treatment were also observed in 32D cells overexpressing the basic helix-loop-helix protein (bHLH), HES1, consistent with activation of the CBF1 pathway. Taken together, our data suggest that Notch signaling enhances 32D cell survival, promotes entry into granulopoiesis, and inhibits postmitotic differentiation through a CBF1-dependent pathway.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据